Vomiting News and Research

RSS

Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.

Parents struggle with what to do when their child has headache, shows study

Parents sometimes struggle with what to do when their child has a headache: go to the ER, to the doctor, or wait it out at home, a new national poll suggests.

16 Jul 2018

Infants have less severe food-induced anaphylaxis unlike older children

Symptoms of food-induced anaphylaxis in infants are much less severe than in toddlers and older children, according to a study from Ann & Robert H. Lurie Children's Hospital of Chicago published in the Annals of Allergy, Asthma and Immunology.

11 Jul 2018

Gene therapy study shows promise for chronic kidney disease

A study has shown that a viral vector can deliver genetic material to damaged kidney cells, potentially providing a treatment that can slow or reverse chronic kidney disease.

6 Jul 2018

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that Japan's Pharmaceuticals and Medical Devices Agency has approved LYNPARZA tablets for use in patients with unresectable or recurrent BRCA-mutated, human epidermal growth factor receptor 2 -negative breast cancer who have received prior chemotherapy.

2 Jul 2018

Antidepressant use in people with COPD linked to increased risk of death and hospitalization

Antidepressant use in people with chronic obstructive pulmonary disease is associated with a 20 percent increase in likelihood of death and a 15 percent increase in likelihood of hospitalization due to related symptoms, finds a new study led by researchers at St. Michael's Hospital.

26 Jun 2018

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.

25 Jun 2018

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

Drug used to treat opioid dependence poses serious health risks in exposed children

A new study published online today by Pediatrics and conducted by researchers at the Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children's Hospital found that from January 2007 through December 2016 there were more than 11,000 calls to US Poison Centers for pediatric exposures to buprenorphine – a prescription opioid medication used to treat opioid use disorder.

25 Jun 2018

Scientists discover vaccine that may rapidly fight cholera-causing bacteria

A tricked-out cholera vaccine starts protecting against the deadly disease within a day, experiments in rabbits suggest.

14 Jun 2018

Study identifies factors that increase antibiotic use among travelers

Travelers carrying standby antibiotics take them more often than those traveling without such drugs. Having antibiotics packed in the bags allows their use - against recommendations - also for mild and moderate diarrhea, i.e. cases not requiring medication.

13 Jun 2018

Study shows modest link between mother’s attitude towards baby during pregnancy and later interactions

Mothers who 'connect' with their baby during pregnancy are more likely to interact in a more positive way with their infant after it is born, according to a study carried out at the University of Cambridge. Interaction is important for helping infants learn and develop.

12 Jun 2018

Five warning signs of eating disorders in teenagers

Nearly 3% of teenagers between the ages of 13-18 - boys as well as girls - struggle with food, weight and body image issues severe enough to constitute an eating disorder.

11 Jun 2018

Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today new positive results from its Phase 1/2 study with lumasiran, an investigational RNAi therapeutic targeting glycolate oxidase for the treatment of Primary Hyperoxaluria Type 1.

8 Jun 2018

Researchers identify culprit that spurs damaging inflammation following heart attack

Scientists have zeroed in on a culprit that spurs damaging inflammation in the heart following a heart attack. The guilty party is a type of immune cell that tries to heal the injured heart but instead triggers inflammation that leads to even more damage.

8 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

New mathematical model holds potential to improve treatment for Hepatitis C infection

The University of Surrey has created a new mathematical model that details how the Hepatitis C infection develops and behaves more accurately than previous models. This new model has the potential to improve treatment for the infection that affects 215,000 people in the United Kingdom.

30 May 2018

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

The U.S. Food and Drug Administration today approved Palynziq (pegvaliase-pqpz) for adults with a rare and serious genetic disease known as phenylketonuria (PKU).

25 May 2018

NIH commences first-in-human trial evaluating experimental treatment for Ebola

A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.

24 May 2018

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

Study finds increase in number of calls to US Poison Control Centers about ADHD medication exposures

A new study conducted by the Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children's Hospital found that there were more than 156,000 calls to US Poison Control Centers regarding exposures to attention-deficit hyperactivity disorder medications among children and adolescents 19 years of age and younger from January 2000 through December 2014, averaging 200 calls each week or 29 calls per day.

21 May 2018

Vomiting News and Research

Further Reading

Parents struggle with what to do when their child has headache, shows study

Infants have less severe food-induced anaphylaxis unlike older children

Gene therapy study shows promise for chronic kidney disease

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

Antidepressant use in people with COPD linked to increased risk of death and hospitalization

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Drug used to treat opioid dependence poses serious health risks in exposed children

Scientists discover vaccine that may rapidly fight cholera-causing bacteria

Study identifies factors that increase antibiotic use among travelers

Study shows modest link between mother’s attitude towards baby during pregnancy and later interactions

Five warning signs of eating disorders in teenagers

Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1

Researchers identify culprit that spurs damaging inflammation following heart attack

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

New mathematical model holds potential to improve treatment for Hepatitis C infection

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

NIH commences first-in-human trial evaluating experimental treatment for Ebola

Celgene to share new and updated data around novel hematological therapies

Study finds increase in number of calls to US Poison Control Centers about ADHD medication exposures

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News